Return of Benefit to Society of Publicly Funded Innovations to Combat COVID-19
In response to the COVID-19 pandemic, significant public funds have been invested worldwide into the research, development, and manufacturing of pharmaceutical products to combat the novel coronavirus. Traditionally, intellectual property (IP) rights have been justified in the pharmaceutical sector...
Saved in:
Main Author: | Helen Yu BSc, JD, PhD (Author) |
---|---|
Format: | Book |
Published: |
SAGE Publishing,
2021-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Innovations to combat COVID-19
by: Anuruddha Padeniya, et al.
Published: (2020) -
Impact of COVID-19 on mutual fund returns by style / Jacob Ongaki
by: Ongaki, Jacob
Published: (2023) -
Funding social innovation for health with research funds for development
by: Hannah Akuffo, et al.
Published: (2020) -
PSYCHOLOGICAL FEATURES OF READAPTATION OF POST-COMBATANTS AFTER THE RETURN FROM THE COMBAT ZONE
by: Voshkolup Hanna
Published: (2022) -
Raising funds to create an obese society?
by: Ajith H. Gunatilaka
Published: (2004)